Automation index

How much of a Materials engineer’s job can AI already do?

A tensile curve comes earlier. Picking the alloy so it does not fail in service do not.

This percentage does not predict how many people will lose their jobs.

Task comparison

IS WORK OVER?

27%

AI can already do 27% of this job.

#162 / 623

Materials engineer

Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.

The time saving for each task is estimated separately.

Task	Share	AI	Points
Tests, metallography and the spec. Estimate No public source provides a precise figure. This is our estimate.	18%	48%	+8.6
Shop, heat treatment and the part that fails spec. Estimate No public source provides a precise figure. This is our estimate.	16%	22%	+3.5
Material choice, corrosion and fatigue. Estimate No public source provides a precise figure. This is our estimate.	16%	36%	+5.8
Supplier, certificates and the doubtful batch. Estimate No public source provides a precise figure. This is our estimate.	16%	28%	+4.5
The field failure and the root cause. Estimate No public source provides a precise figure. This is our estimate.	18%	14%	+2.5
That it does not fail, and not swapping the material blind. Estimate No public source provides a precise figure. This is our estimate.	16%	12%	+1.9
Total	100%		27%

Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low

IS WORK OVER?

23%

#311 / 623

Radiation oncologist

Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.

The time saving for each task is estimated separately.

Task	Share	AI	Points
Contouring, fractions and the dose plan. Estimate No public source provides a precise figure. This is our estimate.	16%	48%	+7.7
Clinic, the tumour and what can be irradiated. Estimate No public source provides a precise figure. This is our estimate.	18%	18%	+3.2
Simulation, immobilisation and the machine day. Estimate No public source provides a precise figure. This is our estimate.	16%	22%	+3.5
Side effects, pauses and the patient who cannot take it. Estimate No public source provides a precise figure. This is our estimate.	16%	28%	+4.5
Board, the surgeon and the medical oncologist. Estimate No public source provides a precise figure. This is our estimate.	18%	14%	+2.5
Signing the plan and the dose that does not erase. Estimate No public source provides a precise figure. This is our estimate.	16%	12%	+1.9
Total	100%		23%

Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low